SLRC SLR Investment Corp.
USFinancial ServicesAs of 2026-07-09 16:00
Why SLRC matters now
SLR Investment Corp. (SLRC) is a US stock in Financial Services. The latest InvestLog snapshot shows $12.68 with -0.63% on the session and $691.8M in market capitalization; recent performance reads 1-month -4.17% and YTD -19.66%.
The latest financial table shown here is Q1 2026, with revenue of $49.3M, net income of $17.1M, and EPS of $0.31. Investors can compare that operating picture with valuation signals such as P/E 8.64 and FCF yield -13.5%.
The latest indexable market news headline is "Arcutis vs. Vertex: Which Pharmaceutical Maker Stock Is a Better Buy in 2026?" from Fool - Investing News.
Additional event context on this page matters because analyst consensus is Hold with a median target of $16.00; recent insider activity includes GROSS MICHAEL S filing P-Purchase. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
8.64
PEG
—
P/B
0.68
P/S
3.71
EV/EBITDA
17.01
DCF Value
$156.85
FCF Yield
-13.5%
Div Yield
12.4%
Margins & Returns
Gross Margin
64.0%
Operating Margin
58.1%
Net Margin
49.2%
ROE
9.0%
ROA
3.5%
ROIC
4.2%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $49.3M | $17.1M | $0.31 |
| Q4 2025 | $44.6M | $25.1M | $0.46 |
| FY 2025 | $220.1M | $92.5M | $1.70 |
| Q3 2025 | $45.3M | $23.3M | $0.43 |
Analyst Ratings
Consensus
Hold
Target (Consensus)
$14.50
Target (Median)
$16.00
Target Range
$11.00 - $16.50
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Financial Services
Industry
Asset Management
Country
US
Exchange
—
Beta
0.66
SLR Investment Corp. operates as a specialized investment firm, providing diverse capital solutions to leveraged middle-market businesses. The company's primary focus involves secured credit facilities, encompassing first-lien unitranche and second-lien debt, alongside junior (unsecured) debt instruments and minority equity investments. It actively participates in various corporate finance activities, including leveraged buyouts, strategic acquisitions, balance sheet recapitalizations, growth capital infusions, and general refinancing; on occasion, it also pursues strategic, income-oriented control equity positions. The firm's investment scope spans a highly diversified array of sectors such as aerospace, manufacturing, financial services, consumer goods, technology, media, and utilities, among many others. Additionally, it maintains a specialized emphasis on the life sciences, specifically targeting opportunities within specialty pharmaceuticals, medical devices, biotechnology, healthcare providers, and health technology. SLR Investment Corp. predominantly allocates its capital within the United States. Individual investment commitments typically fall between $5 million and $100 million. It targets companies with annual revenues ranging from $50 million to $1 billion and EBITDA figures between $15 million and $100 million. The company utilizes various financial instruments, including senior secured loans, mezzanine debt, and equity securities. While its equity investments are generally non-controlling, it also explores opportunities in thinly traded public companies and secondary market transactions. The firm generally aims to exit its investments within three years of the initial capital deployment.